Advertisement G-CON, Howorth collaborate for GMP therapeutics manufacturing solutions - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

G-CON, Howorth collaborate for GMP therapeutics manufacturing solutions

G-CON and Howorth Air Technology have entered into a collaboration to offer a flexible pharmaceutical containment solution that will provide a safe and clean environment for GMP therapeutics manufacturing.

Clean air and isolator technologies will use G-CON’s mobile cleanroom PODs and Howorth’s advanced expertise in engineering to enable customers to meet safety and regulatory needs without risking process productivity.

Howorth Air Technology CEO Graham Hind said that the G-CON provides an innovative solution with a quality and service that present the absolute synergies and ingredients.

"The collaboration of G-CON, Howorth and their associates will provide the optimum single-source solutions to an unparalleled level of technology, quality and service. This recipe makes a very exciting era for G-CON, Howorth and our customers," Hind added.

The combination of G-CON’s modular, flexible POD technology and Howorth’s world class system control solutions provides the biopharmaceutical industry with a key resolution that exceeds relevant GMP global standards, to offer an innovative approach that reduces the clients’ time to market.

G-CON Manufacturing chief operating officer Maik Jornitz said, "The combination of G-CON’s cleanroom PODs and Howorth’s containment options meets current biopharmaceutical industry demands, especially with increasing potency of therapeutic drug products or individual patient therapies."

With immediate effect, G-CON’s PODs are available with Howorth as it is the preferred service provider in containment products, aseptic solutions, and hospital solutions.